MedPath

*Local analgesia in total knee replacement: The effect of local analgesia shots on ropivacaine levels in shed blood collected with a retransfusion device and in patients plasma.*

Completed
Conditions
joint wear (osteoarthritis)
own blood donation (autologous blood transfusion)
10023213
Registration Number
NL-OMON34159
Lead Sponsor
Medisch Centrum Haaglanden
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
20
Inclusion Criteria

- primary TKP
- Haemoglobin level above 7.5 mmol/L
- both arms can be used for blood collection

Exclusion Criteria

- allergic for used medication or other local anaesthetics
- major operation within 12 weeks before TKP surgery
- high risk patients for insultus epilepticus
- dutch language not mastered

Study & Design

Study Type
Observational invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>Ropivacaine will be quantified in patient serum (0, 1, 3, 6, 7 and 18-24 h<br /><br>after surgery) and in the shed blood collected with the Bellovac ABT system at<br /><br>the same time points postoperative. </p><br>
Secondary Outcome Measures
NameTimeMethod
<p>- VAS pain scores measured per protocol<br /><br>- Opioid consumption (amount of morfine used with PCA pump) 24, 48 and 72hrs<br /><br>- Several important time points will be documented; start operation, injection<br /><br>of single shot, tourniquet release, leaving recovery and blood samples </p><br>
© Copyright 2025. All Rights Reserved by MedPath